Tg Therapeutics reported $145K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Amgen AMGN:US $ 31247M 849M
Ardelyx ARDX:US $ 0.01M 0M
Arrowhead Research ARWR:US $ 198K 1000
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Corcept Therapeutics CORT:US $ 0.13M 0M
Curis CRIS:US $ 0.92M 0M
Dynavax Technologies DVAX:US $ 0.13M 0M
Gilead Sciences GILD:US $ 1M 0M
Infinity Pharmaceuticals INFI:US $ 0.09M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Novartis NOVN:VX SF 901M 0M
Novavax NVAX:US $ 0.79M 0.02M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Spectrum Pharmaceuticals SPPI:US $ 0.18M 0.01M
Tg Therapeutics TGTX:US $ 0.14M 0M
Verastem VSTM:US $ 0.02M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
Ziopharm Oncology ZIOP:US $ 0.22M 0M